Wyden biomaterials inquiry
This article was originally published in The Gray Sheet
Executive Summary
Staffers from Rep. Ron Wyden's (D-Ore.) office request a meeting with FDA officials to discuss biomaterials availability. Wyden had written HHS Secretary Donna Shalala about potential biomaterials shortages in the spring ("The Gray Sheet" May 9, p. 25). Shalala responded that HHS shares "your desire to avoid any needless disruption to the availability of" permanent implants. Acknowledging that "shortages of biomaterials may occur" with potentially "severe" consequences, Shalala outlined "actions taken" by the department that "demonstrate a commitment to ensuring" American leadership in the area of medical technology